Hge Wetterhus - Medistim ASA VP Marketing
Insider
Hge Wetterhus is VP Marketing of Medistim ASA
| Age | 59 |
| Phone | 47 23 05 96 60 |
| Web | https://www.medistim.com |
Medistim ASA Management Efficiency
The company has return on total asset (ROA) of 0.1953 % which means that it generated a profit of $0.1953 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.3112 %, meaning that it generated $0.3112 on every $100 dollars invested by stockholders. Medistim ASA's management efficiency ratios could be used to measure how well Medistim ASA manages its routine affairs as well as how well it operates its assets and liabilities.Medistim ASA has accumulated 17.08 M in total debt with debt to equity ratio (D/E) of 3.4, implying the company greatly relies on financing operations through barrowing. Medistim ASA has a current ratio of 3.61, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Medistim ASA until it has trouble settling it off, either with new capital or with free cash flow. So, Medistim ASA's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Medistim ASA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Medistim to invest in growth at high rates of return. When we think about Medistim ASA's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Knut Ekern | AF Gruppen ASA | 50 | |
| Lars Nilsson | Kitron ASA | 59 | |
| Anders Neijber | Photocure | N/A | |
| Dag Aasb | Borregaard ASA | 62 | |
| Kari MD | Photocure | N/A | |
| Per Lyngstad | Borregaard ASA | 62 | |
| Cathrin Nylander | Kitron ASA | 56 | |
| Kristin Misund | Borregaard ASA | 58 | |
| Geir Flata | AF Gruppen ASA | 45 | |
| Eirik Wraal | AF Gruppen ASA | 44 | |
| Orjan Svanevik | Arendals Fossekompani ASA | 57 | |
| Kristoffer Asklov | Kitron ASA | 46 | |
| Hanne Watts | Arendals Fossekompani ASA | N/A | |
| Kelly CPCU | AF Gruppen ASA | N/A | |
| David Moskowitz | Photocure | N/A | |
| Zygimantas Dirse | Kitron ASA | 43 | |
| Patricia Kelly | Photocure | N/A | |
| Geoffrey Coy | Photocure | 53 | |
| Gisle Johansen | Borregaard ASA | 64 | |
| Anny en | AF Gruppen ASA | N/A | |
| Per Srlie | Borregaard ASA | 66 | |
Management Performance
Medistim ASA Leadership Team
Elected by the shareholders, the Medistim ASA's board of directors comprises two types of representatives: Medistim ASA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medistim. The board's role is to monitor Medistim ASA's management team and ensure that shareholders' interests are well served. Medistim ASA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medistim ASA's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Thomas Jakobsen, Chief Officer | ||
| Ole Robsrud, CEO AS | ||
| Hakon Grothe, Chief Officer | ||
| Roger Morberg, VP Sales | ||
| Kari Krogstad, CEO Pres | ||
| Helge Borslid, VP Manufacturing | ||
| Mike Farbelow, Pres Inc | ||
| Cindy Kaffai, Country GmbH | ||
| Hge Wetterhus, VP Marketing | ||
| Ole Eiksund, Chief Officer |
Medistim Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Medistim ASA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.31 | |||
| Return On Asset | 0.2 | |||
| Profit Margin | 0.21 % | |||
| Operating Margin | 0.27 % | |||
| Current Valuation | 4.12 B | |||
| Shares Outstanding | 18.26 M | |||
| Shares Owned By Insiders | 14.97 % | |||
| Shares Owned By Institutions | 73.95 % | |||
| Price To Earning | 36.32 X | |||
| Price To Book | 12.24 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Medistim Stock
Medistim ASA financial ratios help investors to determine whether Medistim Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medistim with respect to the benefits of owning Medistim ASA security.